AELIS: Extended runway, developments on track
AELIS Farma hosted an analyst call following their recent funding round, updating on cash (runway to Q4 2026), the use of proceeds, and progress on developmental programs, including the phase 2b asset AEF0117 in CUD and phase 1 projects, along with new areas of interest for pipeline expansion. Proc
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.